Peter Robinson

Peter Robinson is a co-founder and Chief Scientific Officer at Enable Biosciences, where responsibilities include the commercialization of ultrasensitive antibody assays for infectious and autoimmune diseases. Robinson has secured approximately $4.5 million in grants for developing assays aimed at early disease detection and treatment. Previous experience includes serving as a Graduate Student Researcher at Stanford University, collaborating with Carolyn Bertozzi, filing three patents, publishing six papers, and starting a company recognized with multiple awards. Educational qualifications include a Ph.D. in Chemistry and Chemical Biology from the University of California, Berkeley, and additional degrees from Stanford University and Baylor University.